1. 15 Randomized double-blind placebo controlled trial of frontline maintenance vigil immunotherapy (VITAL study) in stage III/IV ovarian cancer: efficacy assessment in BRCA1/2-wt patients. (13th November 2020) Authors: Rocconi, R; Grosen, E; Ghamande, S; Chan, J; Barve, M; Oh, J; Tewari, D; Morris, P; Stevens, E; Bottsford-Miller, J; Tang, M; Aaron, P; Wallraven, G; Bognar, E; Manning, L; Nemunaitis, J; Slomovitz, B; Herzog, T; Monk, B; Coleman, R Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗